|2004||Claranor founded by François Cazalas|
|2005-2008||Prospecting on various markets, including foodstuffs and biomedical|
|2006||Commissioning of the first cap sterilizer - Nestlé Waters Contrex France|
|2008||Start of collaboration with INRA and Fraunhofer Institute|
|2009||Strategic focus on the decontamination of packaging
Commissioning of the first preformed cup sterilizer
|2010||Company moved to Avignon, in premises next to INRA - Team of 17 staff|
|2013|| Team of 25 staff at the Avignon site
Delivery of the 100th unit and setting up of customer service for management and maintenance of the existing installed equipment
Commissioning of the first preform neck sterilizer on an industrial line
|Year||Number of machines in operation|
Since its establishment in October 2004, the company has received four rounds of financing (April 2005, September 2006, December 2009 and April 2012).
Alongside the company's founder, Mr François Cazalas, the capital is now held by the AMUNDI PRIVATE EQUITY and EMERTEC 3E asset management funds, the NATIXIS / Banque Populaire group, the SUCCES EUROPE TEPA law holding company and by a few private investors. PACA Investissement became an investor in 2012.
Claranor is a limited company with a Board of Directors and a Supervisory Board.
Composition of the Board of Directors:
Composition of the Supervisory Board
Claranor is the leader of the Beata Lux program financed by BPI France (French public investment bank), which brings together ten or so industrial and scientific partners. The aim of the program is to develop aseptic pulsed light applications in the food and pharmaceutical industries.